Clinical trialNCT07376486Not, yet, recruitingInterventional

Duodenal pulsENDO as an Early Treatment for Type 2 DM

SponsorChinese University of Hong KongEnrollment40Diabete MellitusT2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Stephen Ng, FRCSEd(Gen)
Prince of Wales Hospital, the Chinese University of Hong Kong
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Hong Kong

Chinese University of Hong Kong
Shatin, Hong Kong
Alice Kong, FRCP(Edin), MDDerek Xia, MDPhilip Chiu, FRCSEd(Gen), MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Sept 2026
Primary completion: 28 Feb 2031
Completion: 30 Aug 2032
Last update posted: 24 Jun 2026
Registered enrollment: 40
Registry id: NCT07376486

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.